PharmaCyte Biotech Gross Profit Growth & History (PMCB)

PharmaCyte Biotech's gross profit was $0 for fiscal 2016.

View full PharmaCyte Biotech company overview

PharmaCyte Biotech annual gross profit history

PharmaCyte Biotech annual gross profit

Fiscal yearPeriod endedGross profitChangeGrowth
20162016-04-30$0$0
20152015-04-30$0$0
20142014-04-30$0−$2,540
20132013-04-30$2,540−$44,635−94.62%
20122012-04-30$47,175−$46,718−49.76%
20112011-04-30$93,893

PharmaCyte Biotech gross profit trends

Over the last five fiscal years, PharmaCyte Biotech's gross profit decreased from $93,893 to $0, a change of −$93,893. The latest reported quarter, Q4 2017, shows $0.

About the metric

What gross profit means

Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.

Calculation and source

SEC-reported and calculated gross profit

TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review PharmaCyte Biotech source filings ↗

Community posts

It’s quiet here.

No posts about PMCB yet. Start the conversation.

Write the first post